Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Garresori H"" wg kryterium: Autor


Wyświetlanie 1-11 z 11
Tytuł :
OC-16 Apixaban as treatment for cancer-associated venous thrombosis: the CAP study.
Autorzy :
Hannevik, T.L. (AUTHOR)
Brekke, J. (AUTHOR)
Enden, T. (AUTHOR)
Frøen, H. (AUTHOR)
Garresori, H. (AUTHOR)
Ghanima, W. (AUTHOR)
Jacobsen, E.M. (AUTHOR)
Paulsen, P.Q. (AUTHOR)
Porojnicu, A.C. (AUTHOR)
Ree, A.H. (AUTHOR)
Sandset, P.M. (AUTHOR)
Torfoss, D. (AUTHOR)
Velle, E.O. (AUTHOR)
Wik, H.S. (AUTHOR)
Dahm, A.E.A. (AUTHOR)
Pokaż więcej
Źródło :
Thrombosis Research. 2021 Supplement 1, Vol. 200, pS15-S16. 2p.
Czasopismo naukowe
Tytuł :
Surgery of the primary tumour in 201 patients with high-grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine-non-neuroendocrine neoplasms.
Autorzy :
Pommergaard HC; ENETS Neuroendocrine Tumor Centre of Excellence, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Department of Surgery and Transplantation, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Nielsen K; ENETS Neuroendocrine Tumor Centre of Excellence, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Department of Surgery and Transplantation, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Department of Endocrinology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Sorbye H; Department of Oncology, Haukeland University Hospital, Bergen, Norway.; Department of Clinical Science, University of Bergen, Bergen, Norway.
Federspiel B; ENETS Neuroendocrine Tumor Centre of Excellence, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Department of Pathology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Tabaksblat EM; ENETS Neuroendocrine Tumor Centre of Excellence, Aarhus University Hospital, Aarhus, Denmark.; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
Vestermark LW; Department of Oncology, Odense University Hospital, Odense, Denmark.
Janson ET; ENETS Neuroendocrine Tumor Centre of Excellence, Uppsala University Hospital, Uppsala, Sweden.; Department of Medical Sciences, Endocrine Oncology, Uppsala University, Uppsala, Sweden.
Hansen CP; ENETS Neuroendocrine Tumor Centre of Excellence, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Department of Surgery and Transplantation, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Ladekarl M; ENETS Neuroendocrine Tumor Centre of Excellence, Aarhus University Hospital, Aarhus, Denmark.; Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.; Department of Oncology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.
Garresori H; Department of Oncology, Stavanger University Hospital, Stavanger, Norway.
Hjortland GO; ENETS Neuroendocrine Tumor Centre of Excellence, Oslo University Hospital, Oslo, Norway.; Department of Oncology, Oslo University Hospital, Oslo, Norway.
Sundlöv A; Department of Oncology, Skåne University Hospital, Lund, Sweden.
Galleberg R; Department of Oncology, Haukeland University Hospital, Bergen, Norway.
Knigge P; ENETS Neuroendocrine Tumor Centre of Excellence, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Department of Endocrinology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, University of Copenhagen and Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Kjaer A; ENETS Neuroendocrine Tumor Centre of Excellence, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Physiology, Nuclear Medicine & PET and Cluster for Molecular Imaging, University of Copenhagen and Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Langer SW; ENETS Neuroendocrine Tumor Centre of Excellence, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Department of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Knigge U; ENETS Neuroendocrine Tumor Centre of Excellence, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Department of Surgery and Transplantation, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.; Department of Endocrinology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Pokaż więcej
Źródło :
Journal of neuroendocrinology [J Neuroendocrinol] 2021 Mar 26, pp. e12967. Date of Electronic Publication: 2021 Mar 26.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Thrombosis and bleedings in a cohort of cancer patients treated with apixaban for venous thromboembolism.
Autorzy :
Hannevik TL; Institute of Clinical Medicine, University of Oslo, P.O. BOX. 1171 Blindern, N-0318 Oslo, Norway; Department of Haematology, Akershus University Hospital, P.O. BOX 1000, N-1478 Lørenskog, Norway. Electronic address: .
Brekke J; Department of Oncology, Haukeland University Hospital, P.O. BOX. 1400, N-5021 Bergen, Norway. Electronic address: .
Enden T; Department of Radiology, Oslo University Hospital, P.O. BOX. 4950 Nydalen, N-0424 Oslo, Norway. Electronic address: .
Frøen H; Department of Medicine, Baerum Hospital, Vestre Viken Hospital Trust, P.O. BOX. 800, N-3004 Drammen, Norway. Electronic address: .
Garresori H; Department of Oncology, Stavanger University Hospital, P.O. BOX. 8100, N-4068 Stavanger, Norway. Electronic address: herish.garresori@sus.no.
Jacobsen EM; Department of Haematology, Oslo University Hospital, P.O. BOX. 4950 Nydalen, N-0424 Oslo, Norway. Electronic address: .
Paulsen PQ; Department of Hematology, St. Olav's University Hospital, P.O. BOX. 3250 Torgarden, N-7006 Trondheim, Norway. Electronic address: .
Porojnicu AC; Department of Oncology, Drammen Hospital, Vestre Viken Hospital Trust, P.O.BOX. 800, N-3004 Drammen, Norway. Electronic address: .
Ree AH; Institute of Clinical Medicine, University of Oslo, P.O. BOX. 1171 Blindern, N-0318 Oslo, Norway; Department of Oncology, Akershus University Hospital, P.O. BOX. 1000, N-1478 Lørenskog, Norway. Electronic address: a.h..
Torfoss D; Department of Oncology, Oslo University Hospital, P.O. BOX. 4950 Nydalen, N-0424 Oslo, Norway. Electronic address: .
Velle EO; Department of Medicine, Volda Hospital, Møre and Romsdal Hospital Trust Volda, P.O. BOX 1600, N-6026 Ålesund, Norway. Electronic address: .
Wik HS; Department of Haematology, Oslo University Hospital, P.O. BOX. 4950 Nydalen, N-0424 Oslo, Norway. Electronic address: .
Ghanima W; Institute of Clinical Medicine, University of Oslo, P.O. BOX. 1171 Blindern, N-0318 Oslo, Norway; Clinic of Internal Medicine, Østfold Hospital, P.O. BOX 300, N-1714 Grålum, Norway.
Sandset PM; Institute of Clinical Medicine, University of Oslo, P.O. BOX. 1171 Blindern, N-0318 Oslo, Norway. Electronic address: .
Dahm AEA; Institute of Clinical Medicine, University of Oslo, P.O. BOX. 1171 Blindern, N-0318 Oslo, Norway; Department of Haematology, Akershus University Hospital, P.O. BOX 1000, N-1478 Lørenskog, Norway. Electronic address: .
Pokaż więcej
Źródło :
Thrombosis research [Thromb Res] 2020 Dec; Vol. 196, pp. 238-244. Date of Electronic Publication: 2020 Aug 28.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
PALLiON - PALLiative care Integrated in ONcology: study protocol for a Norwegian national cluster-randomized control trial with a complex intervention of early integration of palliative care.
Autorzy :
Hjermstad MJ; Regional Advisory Unit in Palliative Care, Department of Oncology, Oslo University Hospital, Oslo, Norway. .; European Palliative Care Research Centre (PRC), Department of Oncology, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Oslo, Norway. .
Aass N; Regional Advisory Unit in Palliative Care, Department of Oncology, Oslo University Hospital, Oslo, Norway.; European Palliative Care Research Centre (PRC), Department of Oncology, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Andersen S; University Hospital of North Norway, Tromsø, Norway.; UiT, The Arctic University of Norway, Tromsø, Norway.
Brunelli C; Palliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Dajani O; European Palliative Care Research Centre (PRC), Department of Oncology, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Garresori H; Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway.
Hamre H; Department of Oncology, Akershus University Hospital, Nordbyhagen, Norway.
Haukland EC; Department of Oncology and Palliative Care, Nordland Hospital Trust, Bodø, Norway.
Holmberg M; Department of Oncology and Palliative Care, Førde Hospital Trust, Førde, Norway.
Jordal F; Department of Clinical Oncology, Østfold Hospital Trust, Grålum, Norway.
Krogstad H; Cancer Clinic, St. Olavs hospital, Trondheim university hospital, Trondheim, Norway.
Lundeby T; Regional Advisory Unit in Palliative Care, Department of Oncology, Oslo University Hospital, Oslo, Norway.; European Palliative Care Research Centre (PRC), Department of Oncology, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Løhre ET; Cancer Clinic, St. Olavs hospital, Trondheim university hospital, Trondheim, Norway.
Mjåland S; Center for Cancer Treatment, Sorlandet Hospital, Kristiansand, Norway.
Nordbø A; Department of Oncology and Palliative Care, Vestfold Hospital Trust, Tønsberg, Norway.
Paulsen Ø; European Palliative Care Research Centre (PRC), Department of Oncology, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Palliative Care Unit, Telemark Hospital Trust, Skien, Norway.
Schistad Staff E; Department of Oncology, Ålesund Hospital Trust, Ålesund, Norway.
Wester T; Regional Advisory Unit in Palliative Care, Department of Oncology, Oslo University Hospital, Oslo, Norway.
Kaasa S; Regional Advisory Unit in Palliative Care, Department of Oncology, Oslo University Hospital, Oslo, Norway.; European Palliative Care Research Centre (PRC), Department of Oncology, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Loge JH; Regional Advisory Unit in Palliative Care, Department of Oncology, Oslo University Hospital, Oslo, Norway.; Institute of Clinical Medicine, University of Oslo, Oslo, Norway.; Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Pokaż więcej
Źródło :
Trials [Trials] 2020 Apr 02; Vol. 21 (1), pp. 303. Date of Electronic Publication: 2020 Apr 02.
Typ publikacji :
Clinical Trial Protocol; Journal Article
MeSH Terms :
Transitional Care*
Neoplasms/*therapy
Palliative Care/*methods
Patient Education as Topic/*methods
Adaptation, Psychological ; Caregivers/education ; Caregivers/psychology ; Health Knowledge, Attitudes, Practice ; Health Personnel/education ; Humans ; Medical Oncology ; Multicenter Studies as Topic ; Neoplasms/pathology ; Neoplasms/psychology ; Norway ; Patient Satisfaction ; Quality of Life ; Randomized Controlled Trials as Topic ; Referral and Consultation ; Time Factors
Czasopismo naukowe
Tytuł :
Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer.
Autorzy :
Lapin M; Department of Haematology and Oncology, Stavanger University Hospital, 4068, Stavanger, Norway. .; Laboratory for Molecular Biology, Stavanger University Hospital, 4068, Stavanger, Norway. .
Oltedal S; Department of Haematology and Oncology, Stavanger University Hospital, 4068, Stavanger, Norway.; Laboratory for Molecular Biology, Stavanger University Hospital, 4068, Stavanger, Norway.
Tjensvoll K; Department of Haematology and Oncology, Stavanger University Hospital, 4068, Stavanger, Norway.; Laboratory for Molecular Biology, Stavanger University Hospital, 4068, Stavanger, Norway.
Buhl T; Department of Haematology and Oncology, Stavanger University Hospital, 4068, Stavanger, Norway.; Laboratory for Molecular Biology, Stavanger University Hospital, 4068, Stavanger, Norway.
Smaaland R; Department of Haematology and Oncology, Stavanger University Hospital, 4068, Stavanger, Norway.; Laboratory for Molecular Biology, Stavanger University Hospital, 4068, Stavanger, Norway.
Garresori H; Department of Haematology and Oncology, Stavanger University Hospital, 4068, Stavanger, Norway.
Javle M; Department of Gastrointestinal (GI) Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Glenjen NI; Department of Oncology, Haukeland University Hospital, Bergen, Norway.
Abelseth BK; Department of Oncology, Haukeland University Hospital, Bergen, Norway.
Gilje B; Department of Haematology and Oncology, Stavanger University Hospital, 4068, Stavanger, Norway.; Laboratory for Molecular Biology, Stavanger University Hospital, 4068, Stavanger, Norway.
Nordgård O; Department of Haematology and Oncology, Stavanger University Hospital, 4068, Stavanger, Norway.; Laboratory for Molecular Biology, Stavanger University Hospital, 4068, Stavanger, Norway.
Pokaż więcej
Źródło :
Journal of translational medicine [J Transl Med] 2018 Nov 06; Vol. 16 (1), pp. 300. Date of Electronic Publication: 2018 Nov 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cell-Free Nucleic Acids/*blood
Cell-Free Nucleic Acids/*chemistry
Pancreatic Neoplasms/*blood
Pancreatic Neoplasms/*pathology
Adult ; Aged ; Aged, 80 and over ; Case-Control Studies ; Female ; Humans ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Multivariate Analysis ; Neoplasm Staging ; Prognosis ; Proportional Hazards Models ; Survival Analysis
Czasopismo naukowe
Tytuł :
Development of EirV3: A Computer-Based Tool for Patient-Reported Outcome Measures in Cancer.
Autorzy :
Krogstad H; Hilde Krogstad, Cinzia Brunelli, Kari Sand, Tarje Halvorsen, Stein Kaasa, Jon Håvard Loge, Erik Torbjørn Løhre, Sunil X. Raj, and Marianne Jensen Hjermstad, European Palliative Care Research Centre, Norwegian University of Science and Technology (NTNU) and St Olavs Hospital, Trondheim University Hospital; Hilde Krogstad, Tarje Halvorsen, Erik Torbjørn Løhre, and Sunil X. Raj, Cancer Clinic, St Olavs Hospital, Trondheim University Hospital; Eivind Andersen, NTNU Technology Transfer AS, Trondheim; Stein Kaasa, Jon Håvard Loge, and Marianne Jensen Hjermstad, Oslo University Hospital, Oslo; Herish Garresori, Stavanger University Hospital, Stavanger; Ellinor C. Haukland, Nordland Hospital Trust, Bodø; Frode Jordal, Østfold Hospital Trust, Grålum, Norway; and Cinzia Brunelli, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milano, Italy.
Brunelli C; Hilde Krogstad, Cinzia Brunelli, Kari Sand, Tarje Halvorsen, Stein Kaasa, Jon Håvard Loge, Erik Torbjørn Løhre, Sunil X. Raj, and Marianne Jensen Hjermstad, European Palliative Care Research Centre, Norwegian University of Science and Technology (NTNU) and St Olavs Hospital, Trondheim University Hospital; Hilde Krogstad, Tarje Halvorsen, Erik Torbjørn Løhre, and Sunil X. Raj, Cancer Clinic, St Olavs Hospital, Trondheim University Hospital; Eivind Andersen, NTNU Technology Transfer AS, Trondheim; Stein Kaasa, Jon Håvard Loge, and Marianne Jensen Hjermstad, Oslo University Hospital, Oslo; Herish Garresori, Stavanger University Hospital, Stavanger; Ellinor C. Haukland, Nordland Hospital Trust, Bodø; Frode Jordal, Østfold Hospital Trust, Grålum, Norway; and Cinzia Brunelli, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milano, Italy.
Sand K; Hilde Krogstad, Cinzia Brunelli, Kari Sand, Tarje Halvorsen, Stein Kaasa, Jon Håvard Loge, Erik Torbjørn Løhre, Sunil X. Raj, and Marianne Jensen Hjermstad, European Palliative Care Research Centre, Norwegian University of Science and Technology (NTNU) and St Olavs Hospital, Trondheim University Hospital; Hilde Krogstad, Tarje Halvorsen, Erik Torbjørn Løhre, and Sunil X. Raj, Cancer Clinic, St Olavs Hospital, Trondheim University Hospital; Eivind Andersen, NTNU Technology Transfer AS, Trondheim; Stein Kaasa, Jon Håvard Loge, and Marianne Jensen Hjermstad, Oslo University Hospital, Oslo; Herish Garresori, Stavanger University Hospital, Stavanger; Ellinor C. Haukland, Nordland Hospital Trust, Bodø; Frode Jordal, Østfold Hospital Trust, Grålum, Norway; and Cinzia Brunelli, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milano, Italy.
Andersen E; Hilde Krogstad, Cinzia Brunelli, Kari Sand, Tarje Halvorsen, Stein Kaasa, Jon Håvard Loge, Erik Torbjørn Løhre, Sunil X. Raj, and Marianne Jensen Hjermstad, European Palliative Care Research Centre, Norwegian University of Science and Technology (NTNU) and St Olavs Hospital, Trondheim University Hospital; Hilde Krogstad, Tarje Halvorsen, Erik Torbjørn Løhre, and Sunil X. Raj, Cancer Clinic, St Olavs Hospital, Trondheim University Hospital; Eivind Andersen, NTNU Technology Transfer AS, Trondheim; Stein Kaasa, Jon Håvard Loge, and Marianne Jensen Hjermstad, Oslo University Hospital, Oslo; Herish Garresori, Stavanger University Hospital, Stavanger; Ellinor C. Haukland, Nordland Hospital Trust, Bodø; Frode Jordal, Østfold Hospital Trust, Grålum, Norway; and Cinzia Brunelli, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milano, Italy.
Garresori H; Hilde Krogstad, Cinzia Brunelli, Kari Sand, Tarje Halvorsen, Stein Kaasa, Jon Håvard Loge, Erik Torbjørn Løhre, Sunil X. Raj, and Marianne Jensen Hjermstad, European Palliative Care Research Centre, Norwegian University of Science and Technology (NTNU) and St Olavs Hospital, Trondheim University Hospital; Hilde Krogstad, Tarje Halvorsen, Erik Torbjørn Løhre, and Sunil X. Raj, Cancer Clinic, St Olavs Hospital, Trondheim University Hospital; Eivind Andersen, NTNU Technology Transfer AS, Trondheim; Stein Kaasa, Jon Håvard Loge, and Marianne Jensen Hjermstad, Oslo University Hospital, Oslo; Herish Garresori, Stavanger University Hospital, Stavanger; Ellinor C. Haukland, Nordland Hospital Trust, Bodø; Frode Jordal, Østfold Hospital Trust, Grålum, Norway; and Cinzia Brunelli, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milano, Italy.
Halvorsen T; Hilde Krogstad, Cinzia Brunelli, Kari Sand, Tarje Halvorsen, Stein Kaasa, Jon Håvard Loge, Erik Torbjørn Løhre, Sunil X. Raj, and Marianne Jensen Hjermstad, European Palliative Care Research Centre, Norwegian University of Science and Technology (NTNU) and St Olavs Hospital, Trondheim University Hospital; Hilde Krogstad, Tarje Halvorsen, Erik Torbjørn Løhre, and Sunil X. Raj, Cancer Clinic, St Olavs Hospital, Trondheim University Hospital; Eivind Andersen, NTNU Technology Transfer AS, Trondheim; Stein Kaasa, Jon Håvard Loge, and Marianne Jensen Hjermstad, Oslo University Hospital, Oslo; Herish Garresori, Stavanger University Hospital, Stavanger; Ellinor C. Haukland, Nordland Hospital Trust, Bodø; Frode Jordal, Østfold Hospital Trust, Grålum, Norway; and Cinzia Brunelli, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milano, Italy.
Haukland EC; Hilde Krogstad, Cinzia Brunelli, Kari Sand, Tarje Halvorsen, Stein Kaasa, Jon Håvard Loge, Erik Torbjørn Løhre, Sunil X. Raj, and Marianne Jensen Hjermstad, European Palliative Care Research Centre, Norwegian University of Science and Technology (NTNU) and St Olavs Hospital, Trondheim University Hospital; Hilde Krogstad, Tarje Halvorsen, Erik Torbjørn Løhre, and Sunil X. Raj, Cancer Clinic, St Olavs Hospital, Trondheim University Hospital; Eivind Andersen, NTNU Technology Transfer AS, Trondheim; Stein Kaasa, Jon Håvard Loge, and Marianne Jensen Hjermstad, Oslo University Hospital, Oslo; Herish Garresori, Stavanger University Hospital, Stavanger; Ellinor C. Haukland, Nordland Hospital Trust, Bodø; Frode Jordal, Østfold Hospital Trust, Grålum, Norway; and Cinzia Brunelli, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milano, Italy.
Jordal F; Hilde Krogstad, Cinzia Brunelli, Kari Sand, Tarje Halvorsen, Stein Kaasa, Jon Håvard Loge, Erik Torbjørn Løhre, Sunil X. Raj, and Marianne Jensen Hjermstad, European Palliative Care Research Centre, Norwegian University of Science and Technology (NTNU) and St Olavs Hospital, Trondheim University Hospital; Hilde Krogstad, Tarje Halvorsen, Erik Torbjørn Løhre, and Sunil X. Raj, Cancer Clinic, St Olavs Hospital, Trondheim University Hospital; Eivind Andersen, NTNU Technology Transfer AS, Trondheim; Stein Kaasa, Jon Håvard Loge, and Marianne Jensen Hjermstad, Oslo University Hospital, Oslo; Herish Garresori, Stavanger University Hospital, Stavanger; Ellinor C. Haukland, Nordland Hospital Trust, Bodø; Frode Jordal, Østfold Hospital Trust, Grålum, Norway; and Cinzia Brunelli, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milano, Italy.
Kaasa S; Hilde Krogstad, Cinzia Brunelli, Kari Sand, Tarje Halvorsen, Stein Kaasa, Jon Håvard Loge, Erik Torbjørn Løhre, Sunil X. Raj, and Marianne Jensen Hjermstad, European Palliative Care Research Centre, Norwegian University of Science and Technology (NTNU) and St Olavs Hospital, Trondheim University Hospital; Hilde Krogstad, Tarje Halvorsen, Erik Torbjørn Løhre, and Sunil X. Raj, Cancer Clinic, St Olavs Hospital, Trondheim University Hospital; Eivind Andersen, NTNU Technology Transfer AS, Trondheim; Stein Kaasa, Jon Håvard Loge, and Marianne Jensen Hjermstad, Oslo University Hospital, Oslo; Herish Garresori, Stavanger University Hospital, Stavanger; Ellinor C. Haukland, Nordland Hospital Trust, Bodø; Frode Jordal, Østfold Hospital Trust, Grålum, Norway; and Cinzia Brunelli, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milano, Italy.
Loge JH; Hilde Krogstad, Cinzia Brunelli, Kari Sand, Tarje Halvorsen, Stein Kaasa, Jon Håvard Loge, Erik Torbjørn Løhre, Sunil X. Raj, and Marianne Jensen Hjermstad, European Palliative Care Research Centre, Norwegian University of Science and Technology (NTNU) and St Olavs Hospital, Trondheim University Hospital; Hilde Krogstad, Tarje Halvorsen, Erik Torbjørn Løhre, and Sunil X. Raj, Cancer Clinic, St Olavs Hospital, Trondheim University Hospital; Eivind Andersen, NTNU Technology Transfer AS, Trondheim; Stein Kaasa, Jon Håvard Loge, and Marianne Jensen Hjermstad, Oslo University Hospital, Oslo; Herish Garresori, Stavanger University Hospital, Stavanger; Ellinor C. Haukland, Nordland Hospital Trust, Bodø; Frode Jordal, Østfold Hospital Trust, Grålum, Norway; and Cinzia Brunelli, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milano, Italy.
Løhre ET; Hilde Krogstad, Cinzia Brunelli, Kari Sand, Tarje Halvorsen, Stein Kaasa, Jon Håvard Loge, Erik Torbjørn Løhre, Sunil X. Raj, and Marianne Jensen Hjermstad, European Palliative Care Research Centre, Norwegian University of Science and Technology (NTNU) and St Olavs Hospital, Trondheim University Hospital; Hilde Krogstad, Tarje Halvorsen, Erik Torbjørn Løhre, and Sunil X. Raj, Cancer Clinic, St Olavs Hospital, Trondheim University Hospital; Eivind Andersen, NTNU Technology Transfer AS, Trondheim; Stein Kaasa, Jon Håvard Loge, and Marianne Jensen Hjermstad, Oslo University Hospital, Oslo; Herish Garresori, Stavanger University Hospital, Stavanger; Ellinor C. Haukland, Nordland Hospital Trust, Bodø; Frode Jordal, Østfold Hospital Trust, Grålum, Norway; and Cinzia Brunelli, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milano, Italy.
Raj SX; Hilde Krogstad, Cinzia Brunelli, Kari Sand, Tarje Halvorsen, Stein Kaasa, Jon Håvard Loge, Erik Torbjørn Løhre, Sunil X. Raj, and Marianne Jensen Hjermstad, European Palliative Care Research Centre, Norwegian University of Science and Technology (NTNU) and St Olavs Hospital, Trondheim University Hospital; Hilde Krogstad, Tarje Halvorsen, Erik Torbjørn Løhre, and Sunil X. Raj, Cancer Clinic, St Olavs Hospital, Trondheim University Hospital; Eivind Andersen, NTNU Technology Transfer AS, Trondheim; Stein Kaasa, Jon Håvard Loge, and Marianne Jensen Hjermstad, Oslo University Hospital, Oslo; Herish Garresori, Stavanger University Hospital, Stavanger; Ellinor C. Haukland, Nordland Hospital Trust, Bodø; Frode Jordal, Østfold Hospital Trust, Grålum, Norway; and Cinzia Brunelli, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milano, Italy.
Hjermstad MJ; Hilde Krogstad, Cinzia Brunelli, Kari Sand, Tarje Halvorsen, Stein Kaasa, Jon Håvard Loge, Erik Torbjørn Løhre, Sunil X. Raj, and Marianne Jensen Hjermstad, European Palliative Care Research Centre, Norwegian University of Science and Technology (NTNU) and St Olavs Hospital, Trondheim University Hospital; Hilde Krogstad, Tarje Halvorsen, Erik Torbjørn Løhre, and Sunil X. Raj, Cancer Clinic, St Olavs Hospital, Trondheim University Hospital; Eivind Andersen, NTNU Technology Transfer AS, Trondheim; Stein Kaasa, Jon Håvard Loge, and Marianne Jensen Hjermstad, Oslo University Hospital, Oslo; Herish Garresori, Stavanger University Hospital, Stavanger; Ellinor C. Haukland, Nordland Hospital Trust, Bodø; Frode Jordal, Østfold Hospital Trust, Grålum, Norway; and Cinzia Brunelli, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico, Istituto Nazionale dei Tumori, Milano, Italy.
Pokaż więcej
Źródło :
JCO clinical cancer informatics [JCO Clin Cancer Inform] 2017 Nov; Vol. 1, pp. 1-14.
Typ publikacji :
Journal Article
MeSH Terms :
Patient Reported Outcome Measures*
Software*
Medical Oncology/*methods
Adult ; Aged ; Aged, 80 and over ; Electronic Health Records ; Female ; Humans ; Male ; Medical Records ; Middle Aged ; User-Computer Interface
Czasopismo naukowe
    Wyświetlanie 1-11 z 11

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies